Hyperuricemia Is Independently Associated with Coronary Heart Disease and Renal Dysfunction in Patients with Type 2 Diabetes Mellitus

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Ito, Hiroyuki ^a   Abe, Mariko ^a   Mifune, Mizuo ^a   Oshikiri, Koshiro ^a   Antoku, Shinichi ^a   Takeuchi, Yuichiro ^a   Togane, Michiko ^a  

^a 2 24 18 Higashikoiwa   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; BENZBROMARONE; DIURETIC AGENT; FEBUXOSTAT; HEMOGLOBIN A1C; PROBENECID; URIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC MACROANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DRINKING; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; JAPANESE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT DURATION; URIC ACID BLOOD LEVEL; CORONARY ARTERY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICS;

AGED; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERURICEMIA; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 84859220204     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027817     Document Type: Article

References (42)

1. Feig DI, Kang DH, Johnson RJ, (2008) Uric acid and cardiovascular risk. N Engl J Med 359: 1811-1821.
2. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, et al.(2009) Uric acid and long-term outcomes in CKD. Am J Kidney Dis 53: 796-803.
3. Wen CP, David Cheng TY, Chan HT, Tsai MK, Chung WS, et al.(2010) Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk. Am J Kidney Dis 56: 273-288.
4. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH, (2009) Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 61: 225-232.
5. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, et al.(2010) Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res 62: 170-180.
6. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, et al.(2009) Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 61: 885-892.
7. Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, et al.(2008) Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 125: 232-239.
8. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, et al.(2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164: 1546-1551.
9. Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH MRFIT Research Group(2008) Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 168: 1104-1110.
10. Fang J, Alderman MH, (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283: 2404-2410.
11. Herman JB, Goldbourt U, (1982) Uric acid and diabetes: observations in a population study. Lancet 2 (8292): 240-243.
12. Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, et al.(1988) Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol 127: 321-336.
13. Yuan HJ, Yang XG, Shi XY, Tian R, Zhao ZG, (2011) Association of serum uric acid with different levels of glucose. Chin Med J 124: 1443-1448.
14. Alderman MH, Cohen H, Madhavan S, Kivlighn S, (1999) Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 34: 144-150.
15. Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, et al.(2008) Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 5: 310-316.
16. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN, (2008) Uric acid and the development of metabolic syndrome in women and men. Metabolism 57: 845-852.
17. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, et al.(2003) Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 18: 523-530.
18. Wiik BP, Larstorp AC, Høieggen A, Kjeldsen SE, Olsen MH, et al.(2010) Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Am J Hypertens 23: 845-851.
19. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC, (2008) High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 31: 361-362.
20. Viazzi F, Leoncini G, Vercelli M, Deferrari G, Pontremoli R, (2011) Serum uric acid levels predict new-onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. Diabetes Care 34: 126-128.
21. Rathmann W, Hauner H, Dannehl K, Gries FA, (1993) Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Diabete Metab 19: 159-166.
22. Mazza A, Zamboni S, Rizzato E, Pessina AC, Tikhonoff V, et al.(2007) Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL). Acta Diabetol 44: 99-105.
23. Ioachimescu AG, Brennan DM, Hoar BM, Kashyap SR, Hoogwerf BJ, (2007) Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study. Diabet Med 24: 1369-1374.
24. Lehto S, Niskanen L, Rönnemaa T, Laakso M, (1998) Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29: 635-639.
25. Zoppini G, Targher G, Negri C, Stoico V, Perrone F, et al.(2009) Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 32: 1716-1720.
26. Tseng CH, (2004) Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes. Diabet Med 21: 724-749.
27. Ong G, Davis WA, Davis TM, (2010) Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 53: 1288-1294.
28. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al.(2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kid Dis 53: 982-992.
29. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (203) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12.
30. Japanese Society of Gout and Nucleic Acid Metabolism(2010) Guideline for the management of hyperuricemia and gout (2nd ed.). Tokyo Medical Review Co., Ltd.
31. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, et al.(2010) Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Invest 1: 213-228.
32. Editorial Committee for the Treatment Guide for Diabetes(2007) Treatment Guide for Diabetes 2007. Tokyo Japan Diabetes Society.
33. Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, et al.(2010) The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol 9: 18.
34. Li Q, Yang Z, Lu B, Wen J, Ye Z, et al.(2011) Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 10: 72.
35. Choi HK, Mount DB, Reginato AM, (2005) Pathogenesis of gout. Ann Intern Med 143: 499-516.
36. Facchini F, Chen YD, Hollenbeck CB, Reaven GM, (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266: 3008-3011.
37. ter Maaten JC, Voorburg A, de Vries PM, ter Wee PM, Donker AJ, et al.(1998) Relationship between insulin's haemodynamic effects and insulin-mediated glucose uptake. Eur J Clin Invest 28: 279-284.
38. Muscelli E, Natali A, Bianchi S, Bigazzi R, Galvan AQ, et al.(1996) Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 9: 746-752.
39. Tseng CH, (2005) Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 68: 796-801.
40. Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, et al.(2008) Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism 57: 625-629.
41. Ito H, Takeuchi Y, Ishida H, Antoku S, Abe M, et al.(2010) High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria. Nephrol Dial Transplant 25: 1161-1167.
42. Noman A, Ang DS, Ogston S, Lang CC, Struthers AD, (2010) Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 375: 2161-2167.